Linda Lebon

General Counsel en OSE IMMUNOTHERAPEUTICS .

58 años

Health Technology

Consumer Services

Perfil

Linda Lebon is currently the Chief Regulatory Officer at OSE Immunotherapeutics SA since 2021.
Prior to this, she worked as the Chief Regulatory Officer at Bone Therapeutics SA from 2018 to 2021.
Before that, she held the position of Vice President-Regulatory Affairs at argenx SE and Director-Regulatory Affairs at iTeos Therapeutics SA. Ms. Lebon holds an MBA from École des Hautes Études Commerciales de Paris and a graduate degree from Centre Hospitalier Universitaire de Liege.

Cargos activos de Linda Lebon

Empresas	Cargo	Inicio
OSE IMMUNOTHERAPEUTICS	General Counsel	20/12/2021

Todos los cargos activos de Linda Lebon

Antiguos cargos conocidos de Linda Lebon.

Empresas	Cargo	Fin
BIOSENIC SA	General Counsel	01/09/2021
ARGENX SE	General Counsel	-
iTeos Therapeutics SA iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology iTeos Therapeutics SA engages in the discovery of immunomodulators for cancer therapy. It operates as a biotechnology company which focuses on targeting metabolism of the tumor microenvironment through development of small-molecule immunomodulators for cancer treatment. The firm develops small molecules designed to target the tumor microenvironment by inhibiting cancer-induced immune suppression. Targeting such resistance mechanisms will enhance the clinical efficacy of both standards of care treatments as well as the newer immunomodulatory therapies based on the blockade of immune checkpoints. The company was founded in 2011 by Michel Detheux and Benoit Van den Eynde and is headquartered in Gosselies, Belgium.	General Counsel	-

Ver el detalle de la experiencia de Linda Lebon.

Formación de Linda Lebon.

École des Hautes Études Commerciales de Paris	Masters Business Admin
Centre Hospitalier Universitaire de Liege	Graduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Linda Lebon.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	2
ARGENX SE	Health Technology
OSE IMMUNOTHERAPEUTICS	Health Technology

Empresas privadas	2
Bone Therapeutics SA Bone Therapeutics SA Pharmaceuticals: MajorHealth Technology Bone Therapeutics SA is a cell therapy company, which engages in the regenerative therapy addressing for unmet medical needs in the field of bone diseases and orthopedics. Its products include Allob and JTA-004. The company was founded by Jacques Reymann on June 16, 2006 and is headquartered in Gosselies, Belgium.	Health Technology
iTeos Therapeutics SA iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology iTeos Therapeutics SA engages in the discovery of immunomodulators for cancer therapy. It operates as a biotechnology company which focuses on targeting metabolism of the tumor microenvironment through development of small-molecule immunomodulators for cancer treatment. The firm develops small molecules designed to target the tumor microenvironment by inhibiting cancer-induced immune suppression. Targeting such resistance mechanisms will enhance the clinical efficacy of both standards of care treatments as well as the newer immunomodulatory therapies based on the blockade of immune checkpoints. The company was founded in 2011 by Michel Detheux and Benoit Van den Eynde and is headquartered in Gosselies, Belgium.	Health Technology